Parkinson Study Group – Mentored Clinical Research Award

Ends on 1 April 2024

The mission of the Parkinson Study Group is to advance knowledge about the cause(s), pathogenesis and clinical impact of Parkinson disease and related disorders and to develop and implement scientific strategies to examine promising therapeutic interventions.

The Mentored Clinical Research Award is funded by grants from the Parkinson’s Foundation and Sunovion to the Parkinson Study Group (PSG). The purpose of this grant is to support patient-oriented clinical research in Parkinson’s disease (PD) or other parkinsonian disorders in order to address the unmet needs of people living with these conditions.

Proposal Criteria

  • The research plan should entail patient-oriented research in PD or other parkinsonian disorders, and address unmet needs of people living with these conditions.
  • The research findings should have the potential for broad application among the PD/parkinsonism community.
  • The work proposed should have potential to lead to advances in clinically relevant treatment options.
  • The proposal should be hypothesis driven and carry an appropriate data analysis plan.
  • The scope of work should be achievable within the 1 year funding period and appropriate for the budget of the award.
  • The project should include a clearly described mentorship plan.

More details

Website: https://parkinson-study-group.org/mentored-clinical-research-award/